BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 22607948)

  • 1. Circulating angiostatin, bFGF, and Tie2/TEK levels and their prognostic impact in bladder cancer.
    Szarvas T; Jäger T; Laszlo V; Kramer G; Klingler HC; vom Dorp F; Romics I; Ergün S; Rübben H
    Urology; 2012 Sep; 80(3):737.e13-8. PubMed ID: 22607948
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Commentary on "circulating angiostatin, bFGF, and Tie2/TEK levels and their prognostic impact in bladder cancer." Szarvas T, Jäger T, Laszlo V, Kramer G, Klingler HC, vom Dorp F, Romics I, Ergün S, Rübben H, Department of Urology, University of Duisburg-Essen, Germany.: J Urol 2012;80(3):13-8 [Epub 2012 May 17].
    Scherr DS
    Urol Oncol; 2014 Feb; 32(2):215. PubMed ID: 24445299
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pretreatment serum levels of bFGF and VEGF and its clinical significance in endometrial carcinoma.
    Dobrzycka B; Mackowiak-Matejczyk B; Kinalski M; Terlikowski SJ
    Gynecol Oncol; 2013 Mar; 128(3):454-60. PubMed ID: 23206584
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhanced stromal syndecan-1 expression is an independent risk factor for poor survival in bladder cancer.
    Szarvas T; Reis H; Kramer G; Shariat SF; Vom Dorp F; Tschirdewahn S; Schmid KW; Kovalszky I; Rübben H
    Hum Pathol; 2014 Apr; 45(4):674-82. PubMed ID: 24656090
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum levels of angiogenic factors and their prognostic relevance in bladder cancer.
    Szarvas T; Jäger T; Droste F; Becker M; Kovalszky I; Romics I; Ergün S; Rübben H
    Pathol Oncol Res; 2009 Jun; 15(2):193-201. PubMed ID: 18807212
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Angiogenic switch of angiopietins-Tie2 system and its prognostic value in bladder cancer.
    Szarvas T; Jäger T; Tötsch M; vom Dorp F; Kempkensteffen C; Kovalszky I; Romics I; Ergün S; Rübben H
    Clin Cancer Res; 2008 Dec; 14(24):8253-62. PubMed ID: 19088043
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of the prognosis indication of VEGFR-1 and VEGFR-2 and Tie2 receptor expression in breast carcinoma.
    Meunier-Carpentier S; Dales JP; Djemli A; Garcia S; Bonnier P; Andrac-Meyer L; Lavaut MN; Allasia C; Charpin C
    Int J Oncol; 2005 Apr; 26(4):977-84. PubMed ID: 15753992
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Urinary basic fibroblast growth factor in bladder cancer patients. Histopathological correlation and clinical potential.
    Gravas S; Bosinakou I; Kehayas P; Giannopoulos A
    Urol Int; 2004; 73(2):173-7. PubMed ID: 15331904
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tie2/Tek expression in breast carcinoma: correlations of immunohistochemical assays and long-term follow-up in a series of 909 patients.
    Dales JP; Garcia S; Bonnier P; Duffaud F; Meunier-Carpentier S; Andrac-Meyer L; Lavaut MN; Allasia C; Charpin C
    Int J Oncol; 2003 Feb; 22(2):391-7. PubMed ID: 12527939
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic and prognostic role of basic fibroblast growth factor in Wilms' tumor patients.
    Lin RY; Argenta PA; Sullivan KM; Adzick NS
    Clin Cancer Res; 1995 Mar; 1(3):327-31. PubMed ID: 9815988
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Are angiogenic factors, cytokines, and soluble adhesion molecules prognostic factors in patients with renal cell carcinoma?
    Dosquet C; Coudert MC; Lepage E; Cabane J; Richard F
    Clin Cancer Res; 1997 Dec; 3(12 Pt 1):2451-8. PubMed ID: 9815646
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum levels of vascular endothelial growth factor as a prognostic factor in bladder cancer.
    Bernardini S; Fauconnet S; Chabannes E; Henry PC; Adessi G; Bittard H
    J Urol; 2001 Oct; 166(4):1275-9. PubMed ID: 11547057
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Are basic fibroblast growth factor and vascular endothelial growth factor prognostic indicators in pediatric patients with malignant solid tumors?
    Tabone MD; Landman-Parker J; Arcil B; Coudert MC; Gerota I; Benbunan M; Leverger G; Dosquet C
    Clin Cancer Res; 2001 Mar; 7(3):538-43. PubMed ID: 11297245
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Basic fibroblast growth factor (bFGF) and vascular endothelial growth factor (VEGF) levels, as prognostic indicators in NSCLC.
    Iwasaki A; Kuwahara M; Yoshinaga Y; Shirakusa T
    Eur J Cardiothorac Surg; 2004 Mar; 25(3):443-8. PubMed ID: 15019676
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic significance of serum osteoprotegerin levels in patients with bladder carcinoma.
    Mizutani Y; Matsubara H; Yamamoto K; Nan Li Y; Mikami K; Okihara K; Kawauchi A; Bonavida B; Miki T
    Cancer; 2004 Oct; 101(8):1794-802. PubMed ID: 15386310
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preoperative plasma levels of interleukin-6 and its soluble receptor predict disease recurrence and survival of patients with bladder cancer.
    Andrews B; Shariat SF; Kim JH; Wheeler TM; Slawin KM; Lerner SP
    J Urol; 2002 Mar; 167(3):1475-81. PubMed ID: 11832773
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Basic fibroblast growth factor and vascular endothelial growth factor in sera from non-small cell lung cancer patients.
    Brattström D; Bergqvist M; Larsson A; Holmertz J; Hesselius P; Rosenberg L; Brodin O; Wagenius G
    Anticancer Res; 1998; 18(2A):1123-7. PubMed ID: 9615776
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Soluble syndecan-1 and serum basic fibroblast growth factor are new prognostic factors in lung cancer.
    Joensuu H; Anttonen A; Eriksson M; Mäkitaro R; Alfthan H; Kinnula V; Leppä S
    Cancer Res; 2002 Sep; 62(18):5210-7. PubMed ID: 12234986
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum angiogenin is not elevated in patients with early B-cell chronic lymphocytic leukemia but is prognostic factor for disease progression.
    Molica S; Vitelli G; Levato D; Giannarelli D; Vacca A; Cuneo A; Ribatti D; Digiesi G
    Eur J Haematol; 2004 Jul; 73(1):36-42. PubMed ID: 15182336
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High insulin-like growth factor mRNA-binding protein 3 (IMP3) protein expression is associated with poor survival in muscle-invasive bladder cancer.
    Szarvas T; vom Dorp F; Niedworok C; Melchior-Becker A; Fischer JW; Singer BB; Reis H; Bánkfalvi Á; Schmid KW; Romics I; Ergün S; Rübben H
    BJU Int; 2012 Sep; 110(6 Pt B):E308-17. PubMed ID: 22500655
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.